Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - carboprost trometamol 332 µg/ml equivalent to 250 µg/ml carboprost - solution for injection - 250 mcg/ml - active: carboprost trometamol 332 µg/ml equivalent to 250 µg/ml carboprost excipient: benzyl alcohol hydrochloric acid sodium chloride sodium hydroxide trometamol water for injection

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - dinoprostone 0.4 mg/ml - vaginal gel - 1mg/3g - active: dinoprostone 0.4 mg/ml excipient: colloidal silicon dioxide triacetin

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - dinoprostone 0.8 mg/ml - vaginal gel - 2mg/3g - active: dinoprostone 0.8 mg/ml excipient: colloidal silicon dioxide triacetin - prostin e2 is indicated for the induction of labour in term or near term women who have favourable induction features; and who have singleton pregnancy with a vertex position.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - dinoprost trometamol 6.71 mg/ml equivalent to to 5 mg/ml dinoprost - solution for injection - 5 mg/ml - active: dinoprost trometamol 6.71 mg/ml equivalent to to 5 mg/ml dinoprost - prostin f2 alpha sterile solution is indicated for term induction of labour and for evacuation of a third trimester foetal death in utero. prostin f2 alpha sterile solution is indicated for aborting a pregnancy between the 16th and 20th weeks of gestation as calculated from the first day of the last normal menstrual period.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - alprostadil 0.5 mg/ml - solution for injection - 0.5 mg/ml - active: alprostadil 0.5 mg/ml excipient: ethanol

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - linezolid 400mg;  ;   - film coated tablet - 400 mg - active: linezolid 400mg     excipient: carnauba wax hyprolose magnesium stearate maize starch opadry white ys-1-18202 powdered cellulose sodium starch glycolate

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - alprostadil 12.8ug equivalent to maximum dose of 10 mcg after reconstitution - powder for injection - 10 mcg - active: alprostadil 12.8ug equivalent to maximum dose of 10 mcg after reconstitution excipient: alfadex hydrochloric acid lactose monohydrate sodium citrate dihydrate sodium hydroxide benzyl alcohol water for injection - the treatment of erectile dysfunction in adult males. may be a useful adjunct to other diagnostic tests in the diagnosis of erectile dysfunction.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - alprostadil 25.6ug equivalent to maximum dose of 20 mcg after reconstitution - powder for injection - 20 mcg - active: alprostadil 25.6ug equivalent to maximum dose of 20 mcg after reconstitution excipient: alfadex hydrochloric acid lactose monohydrate sodium citrate dihydrate sodium hydroxide benzyl alcohol water for injection - the treatment of erectile dysfunction in adult males. may be a useful adjunct to other diagnostic tests in the diagnosis of erectile dysfunction.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - rifabutin 150mg - capsule - 150 mg - active: rifabutin 150mg - mycobutin is indicated for infections caused by mycobacteria, such as m. tuberculosis, m. avium intracellulare complex (mac) and other atypical mycobacteria. in infections caused by mac and other atypical mycobacteria such as m. xenopi, mycobutin has been shown to be effective for the treatment of both disseminated and localised disease, also in immunocompromised hiv positive patients. mycobutin is also indicated for the prophylaxis of m. avium intracellulare complex (mac) infections in immunodepressed patients with cd4 counts lower than or equal to 100/ml. in the treatment of tubercular disease, mycobutin has been shown to be effective for the treatment of patients with chronic pulmonary tuberculosis, even if caused by multidrug-resistant m. tuberculosis strains. in accordance with the commonly accepted criteria for the treatment of mycobacterial infections, mycobutin therapy should always be given in combination with other antimycobacterial drugs not belonging to the family of rifamycins.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - medroxyprogesterone acetate 10mg;   - tablet - 10 mg - active: medroxyprogesterone acetate 10mg   excipient: calcium stearate lactose monohydrate liquid paraffin maize starch purified talc purified water sucrose - provera low dosage (2.5mg, 5mg and 10mg tablets) are indicated for: · diagnosis of primary and secondary amenorrhoea · treatment of dysfunctional (anovulatory) uterine bleeding · opposition of endometrial effects of estrogen in menopausal women being treated with estrogen (hormone replacement therapy [hrt]) · treatment of endometriosis.